ORGANIC
LETTERS
2001
Vol. 3, No. 6
905-908
Synthesis of (±)-Epoxysorbicillinol Using
a Novel Cyclohexa-2,5-dienone with
Synthetic Applications to Other
Sorbicillin Derivatives
Liping H. Pettus, Ryan W. Van De Water, and Thomas R. R. Pettus*
Department of Chemistry and Biochemistry, UniVersity of California at Santa Barbara,
Santa Barbara, California 93106
Received January 10, 2001
ABSTRACT
A novel route to epoxysorbicillinol as well as dimers of sorbicillin is reported. The synthesis issin principlesamenable to enantioselectivity.
The key step is an oxidative dearomatization to produce a stable and highly malleable p-quinol intermediate, which undergoes a highly
diastereoselective epoxidation.
Cyclohexanones 1-3 (Figure 1) belong to a family of
structurally diverse natural products isolated from both
marine and terrestrial sources that encompass a wide range
of biological activities.1 A highly functionalized tautomeric
cyclohexadienone, 4,2 has been proposed as the common
intermediate in the biosynthetic pathway.3b Indeed, several
dimeric members of this natural product family, 2-3 along
with trichodimerol, have yielded to synthesis by resolution
of the racemic precursor 5, followed by its saponification
and dimerization. These investigations3 testify to the dif-
ficulties that surround manipulating a ring system that
contains both a dienic and dienophilic segment, predisposed
toward dimerization.4
We were interested in developing a synthetic method that
avoided resolution of 5 and furnished a sturdier ring system
that was less prone toward dimerization. Such a process
might lead to both monomeric and dimeric members of the
(1) For isolation and medicinal value of sorbicillinoids, see: (a) Andrade,
R.; Ayer, W. A.; Mebe, P. P. Can. J. Chem. 1992, 70, 2526-2535. (b)
Andrade, R.; Ayer, W. A.; Trifonov, L. S. Can. J. Chem. 1996, 74, 371-
379. (c) Andrade, R.; Ayer, W. A.; Trifonov, L. S. Aust. J. Chem. 1997,
50, 255-257. (d) Sperry, S.; Samuels, G. J.; Crews, P. J. Org. Chem. 1998,
63, 10011-10014. (e) Abe, N.; Yamamoto, K.; Murata, T.; Hirota, A.
Tennen Yuki Kagobutsu Toronkai Koen Yoshishu 1999, 41, 553-558. (f)
Abe, N.; Murata, T.; Hirota, A. Biosci., Biotechnol., Biochem. 1998, 62,
661-666. (g) Shirota, O.; Pathak, V.; Hossain, C. F.; Sekita, S.; Takatori,
K.; Satake, M. J. Chem. Soc., Perkin Trans. 1 1997, 20, 2961-2964. (h)
Mazzucco, C. E.; Warr, G. J. Leukocyte Biol. 1996, 60, 271-277. (i) Warr,
G. A.; Veitch, J. A.; Walsh, A. W.; Hesler, G. A.; Pirnik, D. M.; Leet, J.
E.; Lin, P.-F. M.; Medina, I. A.; McBrien, K. D.; J. Antibiot. 1996, 49,
234-240. (j) Gao, Q.; Leet, J. E.; Thomas, S. T.; Matson, J. A.; Bancroft,
D. P. J. Nat. Prod. 1995, 58, 1817-1821.
(3) (a) Barnes-Seeman, D.; Corey, E. J. Org. Lett. 1999, 1, 1503-1504.
(b) Nicolaou, K. C.; Vassilikogiannakis, G.; Simonsen, K. B.; Baran, P. S.;
Zhong, Y.-L.; Vidali, V. P.; Pitsinos, E. N.; Couladouros, E. A. J. Am.
Chem. Soc. 2000, 122, 3071-3079. (c) Nicolaou, K. C.; Simonsen, K. B.;
Vassilikogiannakis, G.; Baran, P. S.; Vidali, V. P.; Pitsinos, E. N.;
Couladouros, E. A. Angew. Chem., Int. Ed. 1999, 38, 3555-3559. (d)
Nicolaou, K. C.; Jautelat, R.; Vassilikogiannakis, G.; Baran, P. S.; Simonsen,
K. B. Chem. Eur. J. 1999, 5, 3651-3665. (e) Wood, J. L.; Thompson, B.
D.; Yusuff, N.; Pflum, D. A. Abstracts of Papers, 219th National Meeting
of the American Chemical Society, San Francisco, CA, March 26-30, 2000;
American Chemical Society: Washington, DC, 2000; ORGN 848.
(4) A [4 + 2] cycloaddition of 4 produces bisorbicillinol 2, while a net
[4 + 4] cycloaddition of 4 results in trichodimerol, see refs 3a,b.
(2) Abe, N.; Sugimoto, O.; Tanji, K.-I.; Hirota, A. J. Am. Chem. Soc.
2000, 122, 12606-12607.
10.1021/ol0155438 CCC: $20.00 © 2001 American Chemical Society
Published on Web 02/22/2001